Status
Conditions
Treatments
About
This is an investigator-initiated, single-center, open-label clinical trial designed to evaluate the safety and PK of the PET tracer [18F]AlF-RESCA-IL2 in patients prior to and during treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
14 participants in 1 patient group
Loading...
Central trial contact
Elisabeth de Vries, MD/PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal